Sellas Life Sciences Group (SLS) closed at $7.88 on November 5, 2026, down 13.8% from the previous close, on volume of 10,314,479 shares (30-day average 6,176,570).
Data as of November 5, 2026.
5-Nov-2026
Globe Newswire (Wed, 4-Nov 9:00 AM ET)
SELLAS hits the 80th event in its Phase 3 REGAL AML study, setting up a final analysis this quarter
Market Chameleon (Wed, 28-Oct 5:15 AM ET)
Globe Newswire (Wed, 28-Oct 8:35 AM ET)
Market Chameleon (Mon, 28-Sep 4:39 AM ET)
Globe Newswire (Fri, 25-Sep 1:00 PM ET)
PRNewswire (Thu, 24-Sep 5:34 PM ET)
Globe Newswire (Wed, 2-Sep 8:30 AM ET)
Strong Cash Position Supports SELLAS as GPS and SLS009 Progress Toward Major Clinical Milestones
Market Chameleon (Wed, 12-Aug 5:12 AM ET)
SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Globe Newswire (Tue, 11-Aug 4:05 PM ET)
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Sellas Life Sciences Group trades on the NASDAQ stock market under the symbol SLS.
As of November 5, 2026, SLS stock price declined to $7.88 with 10,314,479 million shares trading.
SLS has a beta of 0.63, meaning it tends to be less sensitive to market movements. SLS has a correlation of 0.00 to the broad based SPY ETF.
SLS has a market cap of $1.59 billion. This is considered a Small Cap stock.
In the last 3 years, SLS traded as high as $15.88 and as low as $.50.
The top ETF exchange traded funds that SLS belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.
SLS has outperformed the market in the last year with a return of +374.7%, while the SPY ETF gained +9.7%. However, in the most recent history, SLS shares have underperformed the stock market with its stock returning -33.3% in the last 3 month period and -35.1% for the last 2 week period, while SPY has returned -4.7% and -5.2%, respectively.
SLS support price is $8.50 and resistance is $9.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLS shares will trade within this expected range on the day.
